ADA Scientific Sessions 2025 Abstract

Three Decades of Glucose-Lowering Therapy in Patients with Established Coronary Artery Disease—A Real-World Analysis

By Magdalena Neyer, Johannes Vogel, Pascal Elsner, Christoph H. Saely

Study in peoplePopulations

The paper

Magdalena Neyer, Johannes Vogel, Pascal Elsner, Christoph H. Saely

Triesen

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, poster 423-P

doi.org/10.2337/db25-423-p

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs